First Trust Advisors LP Sells 155,689 Shares of Mirion Technologies, Inc. (NYSE:MIR)

First Trust Advisors LP decreased its position in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 58.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 109,257 shares of the company's stock after selling 155,689 shares during the period. First Trust Advisors LP's holdings in Mirion Technologies were worth $1,907,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Barclays PLC lifted its position in shares of Mirion Technologies by 325.0% during the 3rd quarter. Barclays PLC now owns 307,680 shares of the company's stock valued at $3,405,000 after buying an additional 235,288 shares during the last quarter. Artemis Investment Management LLP bought a new position in Mirion Technologies during the fourth quarter worth about $38,155,000. Simon Quick Advisors LLC increased its stake in shares of Mirion Technologies by 49.6% in the fourth quarter. Simon Quick Advisors LLC now owns 24,054 shares of the company's stock worth $420,000 after purchasing an additional 7,978 shares in the last quarter. Exchange Traded Concepts LLC raised its position in shares of Mirion Technologies by 291.4% in the fourth quarter. Exchange Traded Concepts LLC now owns 88,830 shares of the company's stock valued at $1,550,000 after purchasing an additional 66,132 shares during the period. Finally, KBC Group NV lifted its stake in shares of Mirion Technologies by 39.2% during the 4th quarter. KBC Group NV now owns 8,002 shares of the company's stock valued at $140,000 after buying an additional 2,254 shares in the last quarter. 78.51% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on MIR shares. Robert W. Baird lowered their target price on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, April 4th. Citigroup dropped their price objective on Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Finally, B. Riley decreased their price target on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $18.75.

Mirion Technologies Price Performance

Shares of NYSE MIR traded up $0.28 during midday trading on Friday, hitting $16.41. 947,349 shares of the company's stock were exchanged, compared to its average volume of 1,681,783. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43. The business's fifty day moving average price is $14.58 and its two-hundred day moving average price is $15.72. The company has a market cap of $3.81 billion, a price-to-earnings ratio of -86.37 and a beta of 0.74. Mirion Technologies, Inc. has a 12-month low of $9.11 and a 12-month high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The firm had revenue of $202.00 million for the quarter, compared to analysts' expectations of $199.34 million. During the same quarter last year, the company posted $0.06 EPS. The business's quarterly revenue was up 4.9% on a year-over-year basis. As a group, research analysts forecast that Mirion Technologies, Inc. will post 0.39 EPS for the current fiscal year.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.